Profile
Carl A.
Pelzel served as President & Chief Executive Officer at Assertio Therapeutics, Inc. from 2005 to 2011.
He also held the same position at Invenux, Inc. in 2001-2002.
Prior to that, he was SVP-Global Commercial Operations at Chiron Corp.
from 2003 to 2004.
Pelzel received his undergraduate degree from Hartwick College and his graduate degree from Université Paris 1 Panthéon-Sorbonne.
Former positions of Carl A. Pelzel
| Companies | Position | End |
|---|---|---|
Assertio Therapeutics, Inc.
 Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | President | 03/04/2011 |
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Chief Operating Officer | 31/08/2004 |
| Invenux, Inc. | President | 31/10/2002 |
Training of Carl A. Pelzel
| Hartwick College | Undergraduate Degree |
| Université Paris 1 Panthéon-Sorbonne | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Health Technology |
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Health Technology |
| Invenux, Inc. |
- Stock Market
- Insiders
- Carl A. Pelzel
